Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts

Core Insights - Tilray Medical has formed a strategic partnership with Molteni, an Italian pharmaceutical firm, to enhance the availability of medical cannabis extracts for patients in Italy [1][2][3] - The collaboration aims to provide targeted education on medical cannabis therapies through Molteni's extensive network of healthcare professionals [2][3] Company Overview - Tilray Medical is a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom [3] - The company is dedicated to providing safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, Symbios, and Navcora [4] - Tilray has established itself as one of the largest suppliers of medical cannabis across 20 countries and five continents [4] Partnership Details - The partnership will leverage FL Group's regulatory and distribution capabilities alongside Molteni's scientific expertise to expand access to EU-GMP certified cannabis therapies [3] - The focus will be on empowering healthcare practitioners with knowledge and resources for effective pain management solutions [3] About Molteni - Molteni is a specialty pharmaceutical leader in therapeutic solutions for pain management and substance dependence, with operations in over 40 countries [8] - Founded in 1892 and headquartered in Florence, Italy, Molteni has its own manufacturing, R&D, regulatory, supply chain, and commercial capabilities [8]